Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study

This publication has 39 references indexed in Scilit:

• Ewing sarcoma of the ribResults of an intergroup study with analysis of outcome by timing of resection
  The Journal of Thoracic and Cardiovascular Surgery, 2000
• Granulocyte colony stimulating factor permits dose intensification by interval compression in the treatment of Ewing's sarcomas and soft tissue sarcomas in children
  European Journal Of Cancer, 2000
• Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas
  Medical and Pediatric Oncology, 2000
• Chemotherapy Dose-Intensification for Pediatric Patients With Ewing's Family of Tumors and Desmoplastic Small Round-Cell Tumors: A Feasibility Study at St. Jude Children's Research Hospital
  Journal of Clinical Oncology, 1999
• Prognostic Factors in Patients with Localized Ewing’s Sarcoma: The effect on survival of actual received drug dose intensity and of histologic response to induction therapy
  Journal of Chemotherapy, 1997
• Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors
  Cancer, 1996
• Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
  Journal of Clinical Oncology, 1995
• Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone.
  Journal of Clinical Oncology, 1992
• Influence of Doxorubicin Dose Intensity on Response and Outcome for Patients With Osteogenic Sarcoma and Ewing's Sarcoma
  JNCI Journal of the National Cancer Institute, 1991
• Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study.
  Journal of Clinical Oncology, 1991